Dose of dialysis, convection and haemodialysis patients outcome - What the HEMO study doesn't tell us: The European viewpoint

Nephrology Dialysis Transplantation

Volumn 18, Issue 6, 2003, Pages 1061-1065

  Locatelli, Francesco ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

Convection; Dialysis adequacy; Dialysis dose; Dialysis morbidity and mortality; Multicentre trial

Indexed keywords

BETA 2 MICROGLOBULIN; CUPROPHANE; POLYSULFONE;

ADULT; AGED; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; BODY WATER; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS MEMBRANE; DOSE RESPONSE; EUROPE; FACTORIAL ANALYSIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MEMBRANE PERMEABILITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RENAL SYSTEM PARAMETERS; SURVIVAL RATE; THERMODYNAMICS; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RENAL DIALYSIS; RISK FACTORS;

EID: 0037670205     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg252     Document Type: Article

References (20)

1. National Institute of Diabetes, Digestive, Kidney Diseases. USRDS 2002 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD, USA, 2002.
2. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13: 1061-1066
3. Hornberger JC, Chernew M, Petersen J, Garber AM. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 1992; 3: 1227-1237
4. Woods HF, Nandakumar M. Improved outcome for haemodialysis patients treated with high-flux membranes. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 36-42
5. Port FK, Wolfe RA, Hulbert-Shearon TE et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDs dialysis morbidity and mortality study. Am J Kidney Dis 2001; 37: 276-286
6. Locatelli F, Marcelli D, Conte F et al. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int 1999; 55: 286-293
7. Koda Y, Nishi S, Miyazaki S et al. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997; 52: 1096-1101
8. Locatelli F, Mastrangelo F, Redaelli B et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 1996; 50: 1293-1302
9. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019
10. Sargent JA, Gotch FA. Mathematic modeling of dialysis therapy. Kidney Int 1980; [Suppl 10]: S2-S10
11. Depner T, Beck G, Daugirdas J, Kusek J, Eknoyan G. Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis 1999; 33: 142-149
12. The National Cooperative Dialysis Study. Kidney Int 1983; 23: S1-S122
13. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534
14. Keshaviah P. Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int Suppl 1993; 40: S28-S38
15. Held PJ, Port FK, Wolfe RA et al. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50: 550-556
16. Cheung AK, Agodoa LY, Daugirdas JT et al. Effects of hemodialyzer reuse on clearances of urea and β2-microglobulin. The Hemodialysis (HEMO) Study Group. J Am Soc Nephrol 1999; 10: 117-127
17. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 2000; 11: 2344-2350
18. Woods JD, Port FK, Orzol S et al. Clinical and biochemical correlates of starting 'daily' hemodialysis. Kidney Int 1999; 55: 2467-2476
19. Pierratos A. Nocturnal hemodialysis: dialysis for the new millennium. CMAJ 1999; 161: 1137
20. Locatelli F, Hannedouche T, Jacobson S et al. The effect of membrane permeability on ESRD: design of a prospective randomised multicentre trial. J Nephrol 1999; 12: 85-88